Literature DB >> 15258036

Trans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularisation.

A A Okada, T Wakabayashi, E Kojima, Y Asano, T Hida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15258036      PMCID： PMC1772285          DOI： 10.1136/bjo.2003.039719

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.

Authors:  R P Danis; T A Ciulla; L M Pratt; W Anliker
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.

Authors:  Mark C Gillies; Judy M Simpson; Wei Luo; Philip Penfold; Alex B L Hunyor; William Chua; Paul Mitchell; Frank Billson
Journal:  Arch Ophthalmol       Date:  2003-05

3.  Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

Authors:  T A Ciulla; M H Criswell; R P Danis; T E Hill
Journal:  Arch Ophthalmol       Date:  2001-03

4.  Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein.

Authors:  R Carnuccio; M Di Rosa; B Guerrasio; T Iuvone; L Sautebin
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

5.  The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.

Authors:  H Oh; H Takagi; C Takagi; K Suzuma; A Otani; K Ishida; M Matsumura; Y Ogura; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-08       Impact factor: 4.799

6.  Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells.

Authors:  Yu-sheng Wang; Ulrike Friedrichs; Wolfram Eichler; Stephan Hoffmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-01       Impact factor: 3.117

7.  Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Authors:  J K Challa; M C Gillies; P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1998-11

8.  Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis.

Authors:  A A Okada; T Wakabayashi; Y Morimura; S Kawahara; E Kojima; Y Asano; T Hida
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

9.  The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.

Authors:  A D Proia; A Hirakata; J S McInnes; M W Scroggs; I Parikh
Journal:  Exp Eye Res       Date:  1993-12       Impact factor: 3.467
  9 in total
  6 in total

1.  Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation.

Authors:  Alfonso Giovannini; Piergiorgio Neri; Lucia Mercanti; Claudia Bruè
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

2.  Visual improvement following trans-Tenon's retrobulbar triamcinolone acetonide infusion for polypoidal choroidal vasculopathy.

Authors:  Akiko Okubo; Motoko Ito; Taro Kamisasanuki; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-11       Impact factor: 3.117

3.  Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone.

Authors:  Kazuyuki Hirooka; Fumio Shiraga; Shigeto Tanaka; Tetsuya Baba; Hiroshi Mandai
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

4.  Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells.

Authors:  Yoko Miura; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-03       Impact factor: 3.117

5.  Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye.

Authors:  F E Wang; G Shi; M R Niesman; D A Rewolinski; S S Miller
Journal:  Exp Eye Res       Date:  2007-02-11       Impact factor: 3.467

6.  Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series.

Authors:  Piergiorgio Neri; Mara Manoni; Cinzia Fortuna; Marta Lettieri; Cesare Mariotti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2009-09-02       Impact factor: 2.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.